Open access
Aug 2026
Optimal amyloid and tau CSF biomarkers for the detection of amyloid and tau PET positivity in a memory clinic population
Ratios combining biomarkers of both amyloid and tau, such as Aβ42/pTau, consistently outperformed individual biomarkers in detecting amyloid and tau PET positivity and enhanced clinical utility by highlighting ambiguous cases requiring further assessment.
Sophie Mutel, F. Ribaldi, Augusto J. Mendes et al.
· Alzheimer's Research & T... · 0 citations